Galderma gains L'Oréal as a new major shareholder
Keystone-SDA
Select your language
Generated with artificial intelligence.
Listening: Galderma gains L’Oréal as a new major shareholder
Swiss skincare specialist Galderma is entering into a partnership with the French cosmetics group L'Oréal. As part of the cooperation, L'Oréal will acquire a 10% stake in Galderma.
This content was published on
2 minutes
Keystone-SDA
Deutsch
de
Galderma erhält L’Oréal als neuen Grossaktionär
Original
A corresponding letter of intent has been signed with L’Oréal, Galderma announced on Monday. Both companies intend to work together in the future as part of a “scientific partnership” in the research and development of new skin care products.
Among other things, the focus will be on products designed to reduce the signs of skin ageing.
As part of this new partnership, L’Oréal is acquiring a 10% stake in Galderma. An agreement to this effect has been concluded with the sellers Sunshine SwissCo AG (a consortium led by EQT), Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte Ltd. The parties have agreed not to disclose the price of the share package.
There will be no changes to Galderma’s Board of Directors as a result of L’Oréal’s investment.
Translated from German by DeepL/mga
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
Blatten: top Swiss politician appeals for solidarity with landslide victims
This content was published on
Maja Riniker, president of the House of Representatives, called on Switzerland to show solidarity with those people who have lost everything.
This content was published on
In the US, production has been stopped and 280 employees laid off. For the German subsidiaries – with over 600 employees – insolvency proceedings have been filed.
Swiss researchers develop new treatment against lymphoma
This content was published on
The cancer can be effectively combated with the radioactive element terbium. However, the therapy has not yet been tested on humans.
This content was published on
Florian Willet was present when the Sarco suicide capsule was first used in Switzerland in September 2024 and had been placed in pre-trial detention.
This content was published on
At the start of the 113th International Labour Conference in Geneva, Houngbo called for a "more efficient" organisation in front of the 187 member states
Microsoft invests $400 million in Swiss AI expansion
This content was published on
Among other things, the existing data centres in the Geneva and Zurich regions are being expanded as part of this investment.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.